Cabozantinib Tablets and RPL syndrome
Result of checking the interaction of drug Cabozantinib Tablets and disease RPL syndrome for safety when used together.
When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.
Consumer:Reversible posterior leukoencephalopathy syndrome (RPLS) has been reported in patients receiving cabozantinib. It is recommended to discontinue therapy in patients developing RPLS. The safety of reinitiating therapy in patients previously experiencing RPLS is not known. Care and close monitoring should be considered in these patients.
Generic Name: cabozantinib
Brand Name: Cabometyx, Cometriq
Synonyms: Cabozantinib